Should you buy Amundi (AMUN) stock in 2026?

2026-07-31 · By Lubin Danilo, founder of Lubin Investment

AMUN.PA: see the full analysis on Lubin Investment

Amundi validates 6 of my 10 quality criteria, with a solid 27% free cash flow margin and a 4.5% dividend. Its valuation multiple looks cheap at 11.2 times free cash flow, yet my model still shows a 55.9% premium: a concrete example of the trap of a low multiple without enough growth behind it. Here is why.

An asset manager that sells a service, not a physical product

Amundi, a historic subsidiary of Credit Agricole, is Europe's largest asset manager and ranks among the world's top ten. Its business: collecting savings from individuals and institutions (pension funds, insurers) and placing them into funds or ETFs (baskets of exchange-traded securities that track an index), charging a management fee on the assets entrusted to it along the way. Its assets under management approach 2.6 trillion euros in mid-2026, up 6.7% year over year, driven notably by 24 billion euros of net inflows into ETFs and index solutions in the first quarter, of which 16 billion into ETFs alone.

This business model explains a net margin of 24.9% and, above all, a free cash flow margin of 27% (out of every 100 euros of revenue, 27 end up as real, usable cash): managing one more euro of assets costs almost nothing extra once the platform and teams are in place, unlike a factory that must invest to produce one more unit. As a result, earnings-to-cash conversion reaches 109%, among the highest rates I measure: accounting profits turn almost entirely, and even a bit more, into cash that is truly available.

Why my filter validates only 6 out of 10 criteria

Amundi's weak spot is growth: revenue has grown just 2.9% a year on average over five years, and free cash flow per share only 1.8% a year. The recent trajectory shows a company recovering (free cash flow was even negative in 2022, at minus 234 million euros, before rebounding to 1.49 billion in 2023, 1.52 billion in 2024, and 1.73 billion in 2025), but one struggling to clearly accelerate beyond that catch-up.

Cash return on capital employed (Cash ROCE) comes in at just 6.9%, far below my 15% threshold. The structural reason: asset management faces a permanent price war, especially on index products and ETFs, where management fees keep falling under competitive pressure (notably from US players). Amundi's margins have in fact been compressing for five years (costs growing faster than revenue), a direct sign of this fee pressure affecting the whole asset management industry, not just Amundi.

The price: a low P/FCF hiding a classic trap

Amundi trades at just 11.2 times its annual free cash flow (P/FCF), a multiple sitting at the 43.7th percentile of its sector (the asset management sector's median multiple is 13.8 times): at first glance, a reasonable, almost cheap valuation. That is exactly the kind of number that attracts "value" hunters (stocks that look discounted on a simple ratio).

But my reasonable-buy-price model, which projects the five-year cash-per-share trajectory rather than relying on the displayed multiple alone, puts the entry point at roughly $41.61 against a current price of $94.35. That is a 55.9% premium, despite a P/FCF that looked cheap. This is the classic low-multiple trap: a P/FCF of 11 times is only a good deal if cash per share keeps growing at a solid pace. Here, with growth of just 1.8% a year, even a seemingly modest multiple can represent an overpriced stock once the real trajectory is factored in. A low multiple never says, on its own, whether a stock is cheap: it must always be weighed against the growth behind it.

The real debate

Amundi pays a generous dividend, with a 4.5% yield and a payout ratio of 54.9% of earnings, fairly comfortable. The debate centers on the sustainability of growth: can strongly growing ETF inflows durably offset the margin pressure on traditional active management products? Amundi carries almost no net debt (repayable in just 0.07 years of free cash flow, net cash nearly equal to its total debt), giving it real room to invest in growth or keep rewarding shareholders, but that does not change the picture on the price paid today.

How I settle it

Amundi is a decent-quality company (6 out of 10 criteria), with a capital-light business model that converts profits into cash remarkably well (109% conversion), but whose growth has stayed soft for five years. The displayed multiple of 11.2 times creates a false impression of a bargain: my model, which accounts for the real cash-per-share trajectory, shows a 55.9% premium. This is exactly the kind of nuance a single ratio cannot capture. I keep tracking Amundi's page to see whether cash-per-share growth improves, the reason I built my stock analysis tool around trajectory rather than a mere snapshot.

Amundi validates 6 out of 10 criteria: a solid free cash flow margin (27%) and exceptional cash conversion (109%), but soft growth.
Revenue +2.9% a year over five years, free cash flow per share +1.8% a year, after negative free cash flow in 2022 (minus 234 million euros).
Cash ROCE of just 6.9%, a consequence of the permanent price war on management fees, especially on ETFs and index products.
P/FCF of 11.2x, seemingly cheap (43.7th sector percentile), yet my model still shows a 55.9% premium given insufficient cash-per-share growth.
Verdict: a low P/FCF does not automatically mean a good deal. It must always be weighed against the growth trajectory behind it.

FAQ

Why is Amundi's P/FCF so low compared to other quality stocks?

Because the asset management industry faces permanent fee pressure (an ETF price war), which limits growth and weighs on the multiple the market is willing to pay, even for a top-tier player like Amundi.

Does a low P/FCF always mean a good deal?

No. A low multiple is only worthwhile if the cash-per-share growth behind it is sufficient. Amundi trades at 11.2 times free cash flow but grows just 1.8% a year, which is why my model still shows a 55.9% premium.

Does Amundi carry a lot of debt?

No, almost none: its net debt would take just 0.07 years of free cash flow to repay, reflecting net cash nearly equal to its total debt. It is a very healthy balance sheet, typical of an asset management business that needs no factories or inventory.

Should you buy Amundi stock in 2026?

My quality filter validates 6 out of 10 criteria, but my model shows a 55.9% premium versus my reasonable buy price, despite a seemingly cheap multiple. This remains analysis, not personalized investment advice: do your own research.

About the author

Written by Lubin Danilo, founder of Lubin Investment. A self-taught individual investor, I find fundamental analysis fascinating, and it has delivered excellent results. For three years now, my performance has beaten the S&P 500. But analyzing every stock took too much time: sites with incomplete data, calculation methods and criteria never aligned with mine. And spotting the best stocks was just as time-consuming, even with my own well-defined checklist. So I put my software development background to work to build this software, base my investment strategy on its results, and share it with people who share the same passion as me. It judges a company's quality and its price separately, using criteria drawn from the financial literature (Warren Buffett, Michael Mauboussin, Aswath Damodaran).